BlackRock
ENFN

BlackRock’s Enfusion, Inc. ENFN Stock Holding History

BlackRock’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,435,659
Closed -$38.3M – 5637
2025
Q1 		$38.3M Buy
3,435,659
+254,477
+8% +$2.81M ﹤0.01% 2521
2024
Q4 		$32.8M Sell
3,181,182
-52,799
-2% -$510K ﹤0.01% 2725
2024
Q3 		$30.7M Buy
3,233,981
+157,238
+5% +$1.36M ﹤0.01% 2773
2024
Q2 		$26.2M Buy
3,076,743
+506,822
+20% +$4.64M ﹤0.01% 2815
2024
Q1 		$23.8M Buy
2,569,921
+58,994
+2% +$519K ﹤0.01% 2889
2023
Q4 		$24.4M Buy
2,510,927
+176,744
+8% +$1.65M ﹤0.01% 2900
2023
Q3 		$20.9M Buy
2,334,183
+742,356
+47% +$7.05M ﹤0.01% 2920
2023
Q2 		$17.9M Buy
1,591,827
+32,590
+2% +$289K ﹤0.01% 3111
2023
Q1 		$16.4M Sell
1,559,237
-71,591
-4% -$789K ﹤0.01% 3071
2022
Q4 		$15.8M Buy
1,630,828
+122,752
+8% +$1.38M ﹤0.01% 3160
2022
Q3 		$18.6M Sell
1,508,076
-76,557
-5% -$934K ﹤0.01% 3079
2022
Q2 		$16.2M Buy
1,584,633
+241,930
+18% +$2.67M ﹤0.01% 3204
2022
Q1 		$17.1M Buy
1,342,703
+49,953
+4% +$763K ﹤0.01% 3275
2021
Q4 		$27.1M Buy
+1,292,750
New +$26.1M ﹤0.01% 3090

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock's ENFN Position: Q2 2025 in Review

BlackRock sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 3,435,659 shares — an estimated $38.3M sold.

BlackRock first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $38.3M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • BlackRock reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 3,435,659 Enfusion, Inc. shares in Q2 2025, an estimated $38.3M.
  • BlackRock first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • BlackRock's Enfusion, Inc. position peaked at $38.3M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.